|
SLK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.89830381916545E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55669999113428E-09 |
| Normal-vs-Stage2 |
9.74679999999895E-05 |
| Normal-vs-Stage3 |
1.26260002453193E-09 |
| Normal-vs-Stage4 |
5.46180000116081E-08 |
| Stage1-vs-Stage2 |
5.150800E-01 |
| Stage1-vs-Stage3 |
2.401800E-01 |
| Stage1-vs-Stage4 |
2.148800E-01 |
| Stage2-vs-Stage3 |
1.614030E-01 |
| Stage2-vs-Stage4 |
1.312790E-01 |
| Stage3-vs-Stage4 |
7.446800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.26719778903839E-11 |
| Normal-vs-AfricanAmerican |
4.236200E-03 |
| Normal-vs-Asian |
2.47979999978831E-07 |
| Caucasian-vs-AfricanAmerican |
2.250200E-01 |
| Caucasian-vs-Asian |
6.066800E-01 |
| AfricanAmerican-vs-Asian |
1.523780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.73919997795247E-10 |
| Normal-vs-Female |
5.11120035184831E-10 |
| Male-vs-Female |
3.304800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68679999967836E-07 |
| Normal-vs-Age(41-60Yrs) |
3.02999847434648E-11 |
| Normal-vs-Age(61-80Yrs) |
7.18620000172976E-08 |
| Normal-vs-Age(81-100Yrs) |
1.981190E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.889900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.244400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.560000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.445000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.533200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.251400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.231830E-01 |
| Classical-VS-Follicular |
7.442000E-01 |
| Classical-VS-Other |
2.474600E-01 |
| Classical-VS-Normal |
1.53379997591685E-09 |
| Tall-VS-Follicular |
1.998620E-01 |
| Tall-VS-Other |
6.771000E-01 |
| Tall-VS-Normal |
9.34930000084933E-08 |
| Follicular-VS-Other |
3.690400E-01 |
| Follicular-VS-Normal |
1.49599999998973E-06 |
| Other-VS-Normal |
2.043300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.18649567737839E-11 |
| Normal-vs-N1 |
2.59589999496157E-08 |
| N0-vs-N1 |
3.682600E-01 |
|
|
